Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis

References

• Falk RJ, Jennette JC. Thoughts about the classification of small vessel vasculitis. J Nephrol 2004; 17: s3–s9
   PubMedGoogle Scholar
• Radford DJ, Luu NT, Hewins P, Nash GB, Savage CO. Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthritis Rheum 2001; 44: 2851–2861
   PubMedGoogle Scholar
• Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda Janssen BA, Pall A, Emery P, Savage C, Ada D. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002; 110: 955–963
   PubMed Web of Science ®Google Scholar
• Rarok AA, Limburg PC, Kallenberg CG. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol 2003; 74: 3–15
   PubMedGoogle Scholar
• Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, Kimberly RP. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 1994; 153: 1271–1280
   PubMed Web of Science ®Google Scholar
• Harper L, Radford D, Plant T, Drayson M, Adu D, Savage CO. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytoplasmic antibody-positive patients. Arthritis Rheum 2001; 44: 921–930
   PubMedGoogle Scholar
• Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 1992; 41: 375–383
   PubMed Web of Science ®Google Scholar
• Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003; 349: 36–44
   PubMed Web of Science ®Google Scholar
• Kamesh L, Harper L, Savage CO. ANCA-positive vasculitis. J Am Soc Nephrol 2002; 13: 1953–1960
   PubMed Web of Science ®Google Scholar
• Nowack R, Grab I, Flores-Suarèz LF, Schnülle P, Yard B, van der Woude FJ. ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2001; 6: 1631–1637
   Google Scholar
• Birck R, Schmitt WH, Kaelsch IA, van der Woude FJ. Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis. Systematic review. Am J Kidney Dis 2006; 47: 15–23
   PubMed Web of Science ®Google Scholar
• Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Rheumatology 2008; 47: 1515–1520
   PubMed Web of Science ®Google Scholar
• Gao Y, Chen M, Ye H, Guo XH, Zhao MH, Wang HY. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis. Clin Endocrinol 2007; 66: 543–547
   PubMed Web of Science ®Google Scholar
• Chen M, Yu F, Zhang Y, Zhao MH. Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients. Medicine (Baltimore) 2008; 87: 203–209
   PubMedGoogle Scholar
• Liu LJ, Chen M, Yu F, Zhao MH, Wang HY. Evaluation of a new algorithm in classification of systemic vasculitis. Rheumatology (Oxford) 2008; 47: 708–712
   PubMed Web of Science ®Google Scholar
• Chen M, Yu F, Zhang Y, Zou WZ, Zhao MH, Wang HY. Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int 2005; 68: 2225–2259
   PubMed Web of Science ®Google Scholar
• Chen M, Yu F, Zhang Y, Zhao MH. Clinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: A study of 426 patients from a single center. Postgrad Med J 2005; 81: 723–727
   PubMed Web of Science ®Google Scholar
• Chen M, Yu F, Wang SX, Zou WZ, Zhang Y, Zhao MH, Wang HY. Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis. Nephrol Dial Transplant 2007; 22: 139–145
   PubMedGoogle Scholar
• Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187–192
   PubMed Web of Science ®Google Scholar
• Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994; 87: 671–678
   Google Scholar
• Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: Focus on ANCA-associated vasculitis. Ann Rheum Dis 2007; 66: 605–617
   PubMed Web of Science ®Google Scholar
• Cambridge G, Wallace H, Bernstein RM, Leaker B. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br J Rheumatol 1994; 33: 109–114
   PubMedGoogle Scholar
• Ye H, Gao Y, Guo XH, Zhao MH. Titre and affinity of propylthiouracil-induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis. Clin Exp Immunol 2005; 142: 116–119
   PubMed Web of Science ®Google Scholar
• Neuberger MS, Ehrenstein MR, Rada C, Sale J, Batista FD, Williams G, Milstein C. Memory in the B-cell compartment: antibody affinity maturation. Philos Trans R Soc Lond B Biol Sci 2000; 355: 357–360
   PubMedGoogle Scholar